XANTHINE OXIDASE ACTIVATION IN MILD GESTATIONAL HYPERTENSION

REFERENCES

• Roberts J. M., Redman C. W. Pre-eclampsia: More than Pregnancy-Induced Hypertension. Lancet 1993; 341(8858)1447–1451
   PubMed Web of Science ®Google Scholar
• Ness R. B., Roberts J. M. Heterogeneous Causes Constituting the Single Syndrome of Preeclampsia: A Hypothesis and Its Implications. Am. J. Obstet. Gynecol. 1996; 175(5)1365–1370
   PubMed Web of Science ®Google Scholar
• Roberts J. M., Taylor R. N., Musci T. J., Rodgers G. M., Hubel C. A., McLaughlin M. K. Pre-eclampsia: An Endothelial Cell Disorder. Am. J. Obstet. Gynecol. 1989; 161(5)1200–1204
   PubMed Web of Science ®Google Scholar
• Sladek S. M., Magness R. R., Conrad K. P. Nitric Oxide and Pregnancy. Am. J. Physiol. 1997; 272(2 Pt. 2)R441–R463
   PubMedGoogle Scholar
• Stark J. M. Pre-Eclampsia and Cytokine Induced Oxidative Stress. Br. J. Obstet. Gynaecol. 1993; 100(2)105–109
   PubMedGoogle Scholar
• Granger D. N. Role of Xanthine Oxidase and Granulocytes in Ischemia-Reperfusion Injury. Am. J. Physiol. 1988; 255(6 Pt. 2)H1269–H1275
   PubMedGoogle Scholar
• Jarasch E. D., Bruder G., Heid H. W. Significance of Xanthine Oxidase in Capillary Endothelial Cells. Acta Physiol. Scand., Suppl. 1986; 548: 39–46
   PubMedGoogle Scholar
• Hellsten-Westing Y. Immunohistochemical Localization of Xanthine Oxidase in Human Cardiac and Skeletal Muscle. Histochemistry 1993; 100(3)215–222
   Google Scholar
• Many A., Westerhausen-Larson A., Kanbour-Shakir A., Roberts J. M. Xanthine Oxidase/Dehydrogenase is Present in Human Placenta. Placenta 1996; 17(5–6)361–365
   Google Scholar
• Many A., Hubel C. A., Roberts J. M. Hyperuricemia and Xanthine Oxidase in Preeclampsia, Revisited. Am. J. Obstet. Gynecol. 1996; 174(1 Pt. 1)288–291
   PubMed Web of Science ®Google Scholar
• Many A., Friedman S. A., Hubel C. A., Roberts J. M. Xanthine Oxidase Activity in Preeclamptic Women Is Higher in Invasive but Not Villous Trophoblast [Abstract]. J. Soc. Gynecol. Invest. 1996; 3(Suppl.)86A
   Google Scholar
• Roggensack A. M., Zhang Y., Davidge S. T. Evidence for Peroxynitrite Formation in the Vasculature of Women with Preeclampsia. Hypertension 1999; 33(1)83–89
   PubMedGoogle Scholar
• Myatt L., Rosenfield R. B., Eis A. L., Brockman D. E., Greer I., Lyall F. Nitrotyrosine Residues in Placenta. Evidence of Peroxynitrite Formation and Action. Hypertension 1996; 28(3)488–493
   Google Scholar
• Sakuma S., Fujimoto Y., Sakamoto Y., Uchiyama T., Yoshioka K., Nishida H., Fujita T. Peroxynitrite Induces the Conversion of Xanthine Dehydrogenase to Oxidase in Rabbit Liver. Biochem. Biophys. Res. Commun. 1997; 230(2)476–479
   Google Scholar
• Grant D. M., Tang B. K., Kalow W. Variability in Caffeine Metabolism. Clin. Pharmacol. Ther. 1983; 33(5)591–602
   PubMed Web of Science ®Google Scholar
• Grant D. M., Tang B. K., Campbell M. E., Kalow W. Effect of Allopurinol on Caffeine Disposition in Man. Br. J. Clin. Pharmacol. 1986; 21(4)454–458
   Google Scholar
• Kalow W., Tang B. K. Use of Caffeine Metabolite Ratios to Explore CYP1A2 and Xanthine Oxidase Activities. Clin. Pharmacol. Ther. 1991; 50(5 Pt. 1)508–519
   PubMed Web of Science ®Google Scholar
• Kalow W., Tang B. K. The Use of Caffeine for Enzyme Assays: A Critical Appraisal. Clin. Pharmacol. Ther. 1993; 53(5)503–514
   PubMed Web of Science ®Google Scholar
• Birkett D. J., Miners J. O., Valente L., Lillywhite K. J., Day R. O. 1-Methylxanthine Derived from Caffeine as a Pharmacodynamic Probe Oxypurinol Effect. Br. J. Clin. Pharmacol. 1997; 43(2)197–200
   Google Scholar
• Kilbane A. J., Silbart L. K., Manis M., Beitins I. Z., Weber W. W. Human N-Acetylation Genotype Determination with Urinary Caffeine Metabolites. Clin. Pharmacol. Ther. 1990; 47(4)470–477
   Google Scholar
• Entman S. S., Kambam J. R., Bradley C. A., Cousar J. B. Increased Levels of Carboxyhemoglobin and Serum Iron as an Indicator of Increased Red Cell Turnover in Preeclampsia. Am. J. Obstet. Gynecol. 1987; 156(5)1169–1173
   Google Scholar
• Harkness R. A., Simmonds R. J., O'Connor M. C., Webster A. D. Purine Metabolism Studied with High-Pressure Liquid Chromatography [Proceedings]. Biochem. Soc. Trans. 1979; 7(5)1021–1022
   Google Scholar
• Ward P. A., Till G. O., Hatherill J. R., Annesley T. M., Kunkel R. G. Systemic Complement Activation, Lung injury, and products of lipid peroxidation. J. Clin. Invest. 1985; 76(2)517–527
   PubMed Web of Science ®Google Scholar
• Koster J. F., Biemond P., Swaak A. J. Intracellular and Extracellular Sulphydryl Levels in Rheumatoid Arthritis. Ann. Rheum. Dis. 1986; 45(1)44–46
   PubMed Web of Science ®Google Scholar
• Roberts J. M., Hubel C. A. Is Oxidative Stress the Link in the Two-Stage Model of Preeclampsia?. Lancet 1999; 354(9181)788–789
   PubMed Web of Science ®Google Scholar
• Wisdom S. J., Wilson R., McKillop J. H., Walker J. J. Antioxidant Systems in Normal Pregnancy and in Pregnancy-Induced Hypertension. Am. J. Obstet. Gynecol. 1991; 165(6 Pt. 1)1701–1704
   Google Scholar
• Poranen A. K., Ekblad U., Uotila P., Ahotupa M. Lipid Peroxidation and Antioxidants in Normal and Pre-Eclamptic Pregnancies. Placenta 1996; 17(7)401–405
   Web of Science ®Google Scholar
• Wang Y., Walsh S. W. Placental Mitochondria as a Source of Oxidative Stress in Pre-Eclampsia. Placenta 1998; 19(8)581–586
   PubMed Web of Science ®Google Scholar
• Kristal B. S., Vigneau-Callahan K. E., Moskowitz A. J., Matson W. R. Purine Catabolism: Links to Mitochondrial Respiration and Antioxidant Defenses?. Arch. Biochem. Biophys. 1999; 370(1)22–33
   Google Scholar
• Benowitz N. L. Clinical Pharmacology of Caffeine. Annu. Rev. Med. 1990; 41: 277–288
   PubMed Web of Science ®Google Scholar
• Scott N. R., Chakraborty J., Marks V. Urinary Metabolites of Caffeine in Pregnant Women. Br. J. Clin. Pharmacol. 1986; 22(4)475–478
   Google Scholar
• Relling M. V., Lin J. S., Ayers G. D., Evans W. E. Racial and Gender Differences in N-Acetyltransferase, Xanthine Oxidase, and CYP1A2 Activities. Clin. Pharmacol. Ther. 1992; 52(6)643–658
   PubMed Web of Science ®Google Scholar
• Miyamoto Y., Akaike T., Yoshida M., Goto S., Horie H., Maeda H. Potentiation of Nitric Oxide-Mediated Vasorelaxation by Xanthine Oxidase Inhibitors. Proc. Soc. Exp. Biol. Med. 1996; 211(4)366–373
   PubMed Web of Science ®Google Scholar
• Suzuki H., DeLano F. A., Parks D. A., Jamshidi N., Granger D. N., Ishii H., Suematsu M., Zweifach B. W., Schmid-Schonbein G. W. Xanthine Oxidase Activity Associated with Arterial Blood Pressure in Spontaneously Hypertensive Rats. Proc. Natl. Acad. Sci. U. S. A. 1998; 95(8)4754–4759
   PubMed Web of Science ®Google Scholar
• Lacy F., Gough D. A., Schmid-Schonbein G. W. Role of Xanthine Oxidase in Hydrogen Peroxide Production. Free Radical Biol. Med. 1998; 25(6)720–727
   PubMed Web of Science ®Google Scholar
• Lacy F., O'Connor D. T., Schmid-Schonbein G. W. Plasma Hydrogen Peroxide Production in Hypertensives and Normotensive Subjects at Genetic Risk of Hypertension. J. Hypertens. 1998; 16(3)291–303
   PubMed Web of Science ®Google Scholar